secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tyra Biosciences, Inc. (TYRA)
CIK:        0001863127
Form:       8-K
Filed at:   2021-09-17T23:59:59+00:00
Accession:  0001193125-21-276124
Event type: other_material
Sentiment:  positive
Materiality: 0.85
Item codes: 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tyra Biosciences closes IPO of 12.42M shares at $16, raising $198.7M gross proceeds
--------------------------------------------------------------------------------

- IPO of 12.42M shares (includes full underwriter option) at $16.00/share closed on Sep 17, 2021.
- Gross proceeds of $198.7M before underwriting discounts and offering expenses.
- Amended charter to increase authorized common to 500M shares, authorize 50M preferred shares, and establish classified board.
- Bylaws amended to set procedures for stockholder proposals and director nominations effective upon IPO closing.
- Company is an emerging growth company under the JOBS Act.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1863127/000119312521276124/0001193125-21-276124-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1863127/000119312521276124/d220261d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-21-276124

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer